JPAD-Journal of Prevention of Alzheimers Disease

Article	Citations
Association of Cognitive Reserve Indicator with Cognitive Decline and Structural Brain Differences in Middle and Older Age: Findings from the UK Biobank	390
“Back to Braak”: Role of Nucleus Reuniens and Subcortical Pathways in Alzheimer's Disease Progression	207
Amyloid-Related Imaging Abnormalities and Other MRI Findings in a Cognitively Unimpaired Population With and Without Cerebral Amyloid	196
The Scottish Brain Health Service Model: Rationale and Scientific Basis for a National Care Pathway of Brain Health Services in Scotland	194
The Critical Role of Biomarkers for Drug Development Targeting the Biology of Aging	87
Mendelian Randomization Analysis to Assess Whether Magnetic Resonance Imaging Signs of Cerebral Small Vessel Disease Can Cause Cognitive Decline and Dementia	71
Blood Cathepsins on the Risk of Alzheimer's Disease and Related Pathological Biomarkers: Results from Observational Cohort and Mendelian Randomization Study	61
The Relationship between History of Traumatic Brain Injury and Longitudinal Changes in Cortical Thickness among Patients with Alzheimer's Disease	46
Neuroprotective Effects of IVIG against Alzheimer's Disease via Regulation of Antigen Processing and Presentation by MHC Class I Molecules in 3xTg-AD Mice	44
Adjudicating Mild Cognitive Impairment Due to Alzheimer's Disease as a Novel Endpoint Event in the TOMMORROW Prevention Clinical Trial	41
Longitudinal Cognitive Decline in Patients With Mild Cognitive Impairment or Dementia Due to Alzheimer's Disease	36
Effectiveness of Resistance Exercise on Cognitive Function in Animal Models of Alzheimer Disease: A Systematic Review and Meta-Analysis	35
Estimating Socio-Economic Status for Alzheimer's Disease Trials	31
Associations of Blood Pressure Trajectories with Subsequent Cognitive Decline, Dementia and Mortality	29
Meta Analysis of the Correlation between Periodontal Health and Cognitive Impairment in the Older Population	29
Cognitive Performance and Incident Alzheimer's Dementia in Men Versus Women	26
Maximizing the Utility of Alzheimer's Disease Trial Data: Sharing of Baseline A4 and LEARN Data	23
Preferences about Future Alzheimer's Disease Treatments Elicited through an Online Survey Using the Threshold Technique	22
The Geras Solutions Cognitive Test for Assessing Cognitive Impairment: Normative Data from a Population-Based Cohort	22
Multidomain Intervention for the Reversal of Cognitive Frailty Using a Personalized Approach (AGELESS Trial): Recruitment and Baseline Characteristics of Participants	21
Opportunities for Cellular Rejuvenation in Alzheimer's Disease: How Epigenetic Reprogramming and Chaperone-Mediated Autophagy Are Enabling Next Generation Therapeutic Approaches	21
Update to: Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease	20
Universal Prevention of Dementia in Italy: A Document Analysis of the 21 Italian Regional Prevention Plans	19
Evaluation of Clinical Meaningfulness of Fortasyn Connect in Terms of “Time Saved”	19
Validation of the CogDrisk Instrument as Predictive of Dementia in Four General Community-Dwelling Populations	18

Heightened Prevalence of Common Hospital-Treated Infections Preceding Dementia Diagnosis with Accelerated Dementia Onset after Influenza	17
Medical Costs and Caregiver Burden of Delivering Disease-Modifying Alzheimer's Treatments with Different Duration and Route of Administration	17
Progress in the Treatment of Alzheimer's Disease Is Needed – Position Statement of European Alzheimer's Disease Consortium (EADC) Investigators	16
Digital Health Technologies for Alzheimer's Disease and Related Dementias: Initial Results from a Landscape Analysis and Community Collaborative Effort	16
Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study	16
Corrigendum to “Multiomics Blood-Based Biomarkers Predict Alzheimer's Predementia with High Specificity in a Multicentric Cohort Study” [The Journal of Prevention of Alzheimer's Disease 2024;11(3):567	15
Vision, courage, and academic freedom	14
Use of lecanemab and donanemab in the Canadian healthcare system: Evidence, challenges, and areas for future research	13
Editorial Board	13
Erratum to: Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats	13
American's overall and equity-based societal valuation of a disease-modifying Alzheimer's treatment: Results from a discrete choice experiment	12
The associations between fresh vegetable and fruit consumption and plasma and PET biomarkers in preclinical Alzheimer's disease: A cross-sectional and longitudinal study of Chinese population	12
Longitudinal Course of Agitation and Aggression in Patients with Alzheimer's Disease in a Cohort study: Methods, Baseline and Longitudinal Results of the A3C Study	11
Multisensory stimulation reduces neuropsychiatric symptoms and enhances cognitive function in older adults with dementia: A meta-analysis of randomized controlled trials	11
Greater White Matter Hyperintensity Volume Is Associated with the Number of Microhemorrhages in Preclinical Alzheimer's Disease	11
Detection Rates of Mild Cognitive Impairment in Primary Care for the United States Medicare Population	11
Longitudinal associations of carotid artery stiffness with progression of cerebrovascular disease, incident dementia and cognitive decline in older adults	11
Informing etiological heterogeneity of mild cognitive impairment and risk for progression to dementia with plasma p-tau217	10
Key considerations for combination therapy in Alzheimer's clinical trials: Perspectives from an expert advisory board convened by the Alzheimer's drug discovery foundation	10
Expectancy Does Not Predict 18-month Treatment Outcomes with Cognitive Training in Mild Cognitive Impairment	10
Maintaining level of modifiable dementia risk scores is associated with better cognitive outcomes than increasing risk scores: A population-based prospective cohort study	10
INTERCEPT-AD, a phase 1 study of intravenous sabirnetug in participants with mild cognitive impairment or mild dementia due to Alzheimer's disease	10
Artificial intelligence-enabled safety monitoring in Alzheimer's disease clinical trials	10
Association of statins use and genetic susceptibility with incidence of Alzheimer's disease	10
A Japanese Multicenter Study on PET and Other Biomarkers for Subjects with Potential Preclinical and Prodromal Alzheimer's Disease	9
Sample size estimates for biomarker-based outcome measures in clinical trials in autosomal dominant Alzheimer's disease	9
Patient management pathways in dementia – Resource utilisation, diagnosis and drug treatment in the Stockholm region, Sweden	9
Multi-omics analysis of druggable genes to facilitate Alzheimer's disease therapy: A multi-cohort machine learning study	9
Editorial Board	9
The US Expert Panel on the Appropriate Use Recommendations of Aducanumab in Clinical Practice	9
Dietary patterns and blood-based biomarkers of Alzheimer's disease in cognitively intact older adults: Findings from a population-based study	9
Evaluation of Memantine in AAV-AD Rat: A Model of Late-Onset Alzheimer's Disease Predementia	8
Alzheimer's Disease Prevention Health Coaching	8
Amnestic Mild Cognitive Impairment is Characterized by the Inability to Recover from Proactive Semantic Interference across Multiple Learning Trials	8
Ten Years after the National Alzheimer's Plan: Dementia Remains a Hidden Syndrome in France	8
The Clinical Trials Alzheimer's Disease (CTAD) Meeting in San Francisco, Fall 2022, Will Be a Very Exciting Event!	8
Standardizing Electronic Health Record Data on AD/ADRD to Accelerate Health Equity in Prevention, Detection, and Treatment	8
Age, Sex, Hypertension and HDL-C Alter Serum BACE1 Activity in Cognitively Normal Subjects: Implications for Alzheimer's Disease	8
Digital Therapeutics for MCI and Alzheimer's disease: A Regulatory Perspective — Highlights From The Clinical Trials on Alzheimer's Disease conference (CTAD)	7
Association of Preeclampsia with Incident Dementia and Alzheimer's Disease among Women in the Framingham Offspring Study	7
Chronic Pain in Multiple Sites and Dementia: A Vicious Cycle?	7
Personalized Computational Causal Modeling of the Alzheimer Disease Biomarker Cascade	7
Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging	7
Association between Cerebrospinal Fluid sTREM2 Levels and Depression: The Alzheimer's Disease Neuroimaging Initiative Study	7
Relationships of Hypnotics with Incident Dementia and Alzheimer's Disease: A Longitudinal Study and Meta-Analysis	7
Expanding the ATN Framework to Further Personalize Therapies	7
Genetically Determined Alzheimer's Disease Is Associated with Increased Risk of Varicose Vein: A Mendelian Randomization Study	7
Dietary Cholesterol and Dementia Risk	7
Predictive Utility of Plasma Amyloid and Tau for Cognitive Decline in Cognitively Normal Adults	7
Investigating the Impact of Tea Consumption on Cognitive Function and Exploring Tea-Genetic Interactions in Older Adults Aged 65–105 Years: Findings from the 2002–2018 CLHLS Data	7

Sex Difference in the Association between Prior Fracture and Subsequent Risk of Incident Dementia: A Longitudinal Cohort Study	7
Objective and Subjective Measurements of Motor Function: Results from the HELIAD Study	7
Balancing the Conflicting Goals for Treatment of Alzheimer's Disease with Monoclonal Antibodies	7
A Hierarchical Bayesian Latent Class Model for the Diagnostic Performance of Mini-Mental State Examination and Montreal Cognitive Assessment in Screening Mild Cognitive Impairment Due to Alzheimer's D	7
Plasma Oligomer β-Amyloid and White Matter Microstructural Integrity in Cognitively Normal Older Adults According to Cerebral Amyloid Deposition	7
Effects of Non-Invasive Brain Stimulation on Alzheimer's Disease	7
Hypnotics and Incident Dementia: A Risk Assessment	7
Future of Alzheimer's Disease Treatment: Combination Therapy and Precision Medicine	7
Mitochondrial dysfunction as the missing link between circadian syndrome and dementia	6
The Effects of Dual-Task Training on Cognitive and Physical Functions in Older Adults with Cognitive Impairment; A Systematic Review and Meta-Analysis	6
Mechanisms Underlying Non-Pharmacological Dementia Prevention Strategies: A Translational Perspective	6
The Future of AD Clinical Trials with the Advent of Anti-Amyloid Therapies: An CTAD Task Force Report	6
Comparative Efficacy, Safety, Tolerability, and Effectiveness of Antipsychotics in The Treatment of Dementia-Related Psychosis (DRP): A Systematic Literature Review	6
Content	6
Therapeutic Targets for Alzheimer's Disease: Amyloid Vs. Non-Amyloid. Where Does Consensus Lie Today? An CTAD Task Force Report	6
Usability of a Web-Based Registry for Preclinical Alzheimer's Disease: Implications from a Cross-Sectional Online Survey	6
Reevaluating the sleep-dementia link: Methodological gaps and future directions	6
The effect of sleep disturbances on the incidence of dementia for varying lag times	6
‘Time Saved' As a Demonstration of Clinical Meaningfulness and Illustrated Using the Donanemab TRAILBLAZER-ALZ Study Findings	6
Cytomegalovirus Infection and Alzheimer's Disease: A Meta-Analysis	6
Estimates of Current Capacity for Diagnosing Alzheimer's Disease in Sweden and the Need to Expand Specialist Numbers	5
On the 2024 Alzheimer's Association Criteria: Still Not Ready for Clinical Use	5
Platform Trials to Expedite Drug Development in Alzheimer's Disease: A Report from the EU/US CTAD Task Force	5
Healthy dietary patterns in relation to cognitive performance and Alzheimer's disease mortality	5
The Room Where It Happens: Clinician Reflections on Returning Preclinical Alzheimer's Biomarker Results to Research Participants	5
The Role of Thyroid Dysfunction in Alzheimer's Disease: A Systematic Review and Meta-Analysis	5
15th Conference Clinical Trials Alzheimer's Disease, November 29- December 2, 2022, San Francisco, CA, USA: Symposia - Oral Communications - Late Breaking Abstracts (Clinical Trial Alzheimer's Disease	5
Investigating the Factor Structure of the Preclinical Alzheimer Cognitive Composite and Cognitive Function Index across Racial/Ethnic, Sex, and Aβ Status Groups in the A4 Study	5
A Novel Computerized Cognitive Stress Test to Detect Mild Cognitive Impairment	5
Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities	5
Clinical Trial Endpoints and Their Clinical Meaningfulness in Early Stages of Alzheimer's Disease	5
Tackling a Major Deficiency of Diversity in Alzheimer's Disease Therapeutic Trials: An CTAD Task Force Report	5
Consistency between Treatment Effects on Clinical and Brain Atrophy Outcomes in Alzheimer's Disease Trials	5
Burden of Illness in People with Alzheimer's Disease: A Systematic Review of Epidemiology, Comorbidities and Mortality	5
The Association between Peanut and Peanut Butter Consumption and Cognitive Function among Community-Dwelling Older Adults	5
Establishing Clinically Meaningful Change on Outcome Assessments Frequently Used in Trials of Mild Cognitive Impairment Due to Alzheimer's Disease	5
Effects of Folic Acid and Vitamin B12 Supplementation on Cognitive Impairment and Inflammation in Patients with Alzheimer's Disease: A Randomized, Single-Blinded, Placebo-Controlled Trial	5
The Effect of Multidomain Interventions on Global Cognition, Symptoms of Depression and Apathy — A Pooled Analysis of Two Randomized Controlled Trials	5
Item-Level Investigation of Participant and Study Partner Report on the Cognitive Function Index from the A4 Study Screening Data	4
LMTK2 and CRB1 are two novel risk genes for Alzheimer's disease in Han Chinese	4
Pushing through the Barriers: Peer Advice to Increase Physical Activity and Reduce Dementia Risk from Participants in a Massive Open Online Alzheimer's Focused Course	4
MemScreen: A smartphone application for detection of mild cognitive impairment: A validation study	4
Psychometric Properties of the Clinical Dementia Rating — Sum of Boxes and other Cognitive and Functional Outcomes in a Prodromal Alzheimer's Disease Population	4
Projected Savings to Canadian Provincial Budgets from Reduced Long-Term Care Home Utilization Due to a Disease-Modifying Alzheimer's Treatment	4
Elecsys Cerebrospinal Fluid Assays Accurately Distinguish Alzheimer's Disease from Frontotemporal Lobar Degeneration	4
Anti-Hypertensives Reduce the Rate of Alzheimer's Disease Progression: A Cohort Study Linked with Genetic and Neuropathological Analyses	4
The Shape Trail Test Is Sensitive in Differentiating Older Adults with Mild Cognitive Impairment: A Culture-neutral Five-minute Test	4
Non-Genetic Risk Factors of Alzheimer's Disease: An Updated Umbrella Review	4
Modifiable Risk Factors for Accelerated Decline in Processing Speed: Results from Three Dutch Population Cohorts	4
AMBAR: A Therapeutical Approach for Alzheimer's Disease Patients Regardless of Amyloid Status	4
Views and Perceptions of Amyloid Imaging in a Preclinical Alzheimer's Disease Trial	4
Prevalence Estimation of Dementia/Alzheimer's Disease Using Health and Retirement Study Database in the United States	4
Effects of the COVID-19 Pandemic on the Number of New Dementia Diagnoses and the Quality of Dementia Diagnostics and Treatment	4
Evaluating the Performance of Different Criteria in Diagnosing AD and Preclinical AD with the Bayesian Latent Class Model	4
The Effects of Different Exercise Interventions on Patients with Subjective Cognitive Decline: A Systematic Review and Network Meta-Analysis	4
Diagnostic and discriminative accuracy of plasma phosphorylated tau 217 for symptomatic Alzheimerʼs disease in a Chinese cohort	4
Associations between Participant Characteristics and Participant Feedback about an Unsupervised Online Cognitive Assessment in a Research Registry	4
Development and Validation the Mobile Toolbox (MTB) Spelling Test	4
Effectiveness of a Meta-Cognitive Group Intervention for Older Adults with Subjective Cognitive Decline or Mild Cognitive Impairment: The ASPIRE Randomized Controlled Trial	4
Leveraging Diverse Regulated Cell Death Patterns to Identify Diagnosis Biomarkers for Alzheimer's Disease	4
What Are the Remaining Challenges before Blood-Based Biomarkers for Alzheimer's Disease Can Be Used in Clinical Practice?	3
Introduction to the Special Issue on the A4 Study	3
Adding the Topographical Information from Tau-PET to the A/T/(N) Framework: Steps Towards Staging AD in Vivo	3
Content	3
Expert opinion on Centiloid thresholds suitable for initiating anti-amyloid therapy. Summary of discussion at the 2024 spring Alzheimer's Association Research Roundtable	3
Cohort Effects in Alzheimer's Disease Trials: An Empirical Assessment Utilizing Data from the Alzheimer's Disease Cooperative Study	3
Association of Multi-Domain Factors with Cognition in the UK Biobank Study	3
Symposia — Oral Communications — Late Breaking News	3
Fructose Consumption is Associated with a Higher Risk of Dementia and Alzheimer's Disease: A Prospective Cohort Study	3
Enhancing dementia prediction: A 19-year validation of the CAIDE risk score with insulin resistance and APOE ε4 integration in a population-based cohort	3
Dual Task Performance Is Associated with Amyloidosis in Cognitively Healthy Adults	3
Environmental Distractions during Unsupervised Remote Digital Cognitive Assessment	3
Blood-Based Biomarkers for Alzheimer's Disease: Are We There Yet?	3
Posters	3
Determinants of Medical Direct Costs of Care among Patients of a Memory Center	3
US Adults' Likelihood to Participate in Dementia Prevention Drug Trials: Results from the National Poll on Healthy Aging	3
A Randomized Prospective Survey Targeting Knowledge, Barriers, Facilitators and Readiness to Participation in Dementia Research	3
What Is Reasonable and Necessary for Alzheimer Patients from Randomized Clinical Trials to Clinical Practice?	3
Prediction of Alzheimer's Disease Based on 3D Genome Selected circRNA	3
The Journal of Prevention of Alzheimer Disease (JPAD) Is Entering Its Second Decade 2014–2024	3

Longitudinal Trajectories of the Cognitive Function Index in the A4 Study	3
Phase 1 Studies of the Anti-Tau Monoclonal Antibody JNJ-63733657 in Healthy Participants and Participants with Alzheimer's Disease	3
Blood Derived Amyloid Biomarkers for Alzheimer's Disease Prevention	3
Association of dietary fatty acids with longitudinal change in plasma-based biomarkers of Alzheimer's disease	3
Aducanumab Trials EMERGE But Don't ENGAGE	3
Distinct CSF α-synuclein aggregation profiles associated with Alzheimer's disease phenotypes and MCI-to-AD conversion	3
Childhood Secondhand Smoke Exposure and Risk of Dementia in Adulthood	3
Validation, Deployment, and Real-World Implementation of a Modular Toolbox for Alzheimer's Disease Detection and Dementia Risk Reduction: The AD-RIDDLE Project	3
Overtreating Alzheimer's Disease	3
Association between Comorbidity Indices and Functional Autonomy in Individuals with Cognitive Impairment: A Systematic Review	3
How Larger Society Can Give a Helping Hand to Worldwide FINGERS	3
Fish and Shellfish Consumption, Cognitive Health and Mortality from Alzheimer's Disease among US Adults Aged 60 and Older	3
When It Comes to Lecanemab (and Donanemab), How Might We Think about ‘Reasonable and Necessary'?	3
Examining the Diagnostic Accuracy of a Novel Performance-Based Test for Alzheimer's Disease Screening	3
Quantifying Recruitment Source and Participant Communication Preferences for Alzheimer's Disease Prevention Research	3
Periodontal Disease and Alzheimer's: Insights from a Systematic Literature Network Analysis	3
Cohort-Specific Optimization of Models Predicting Preclinical Alzheimer's Disease, to Enhance Screening Performance in the Middle of Preclinical Alzheimer's Disease Clinical Studies	3
Response to Concerns Raised on MRI Surveillance and Clinical Implications of ARIA in Disease Modifying Treatment	3
Reply to: Enhancing Statin Research for Alzheimer's Prevention: Suggestions for Future Studies and Policy Implications	3
Plasma neurofilament light mediates the effects of Apolipoprotein E on brain atrophy and cognitive decline in the comorbid Alzheimer's disease and cerebral small vessel disease	3
Study Protocol of a Comprehensive Activity Promotion Program for the Prevention of Dementia: A Randomized Controlled Trial Protocol	3
Microstructural white matter injury contributes to cognitive decline: Besides amyloid and tau	3
Tau Pathologies Mediate the Associations of Vascular Risk Burden with Cognitive Impairments in Non-demented Elders: The CABLE Study	3
Informal care for people with dementia in Europe	3
Cerebral Phospho-Tau Acts Synergistically with Soluble Aβ42 Leading to Mild Cognitive Impairment in AAV-AD Rats	3
First Experiences with Amyloid-Related Imaging Abnormalities — Yet without Imaging that Can Rule Out Cerebral Injury or Monitor Efficacy of Recommended Management	3
Decreased Gray—White Matter Contrast of [11C]-PiB Uptake in Cognitively Unimpaired Subjects with Severe Obstructive Sleep Apnea	2
White matter hyperintensity severity modifies gut metabolite association with cognitive outcomes	2
Prediction of Cognitive Decline for Enrichment of Alzheimer's Disease Clinical Trials	2
A Statistical Framework for Assessing the Relationship between Biomarkers and Clinical Endpoints in Alzheimer's Disease	2
Blood Biomarkers from Research Use to Clinical Practice: What Must Be Done? A Report from the EU/US CTAD Task Force	2
Who Benefited Most from the Internet-Based Conversational Engagement RCT (I-CONECT)? Application of the Personalized Medicine Approach to a Behavioral Intervention Study	2
High definition transcranial direct current stimulation as an intervention for cognitive deficits in Alzheimer's dementia: A randomized controlled trial	2
Fingolimod ameliorates amyloid deposition and neurodegeneration in APP/PS1 mouse model of Alzheimer's disease	2
Diagnostic Accuracy of Plasma p-tau217 for Detecting Pathological Cerebrospinal Fluid Changes in Cognitively Unimpaired Subjects Using the Lumipulse Platform	2
Informing Alzheimer's Biomarker Communication: Concerns and Understanding of Cognitively Unimpaired Adults During Amyloid Results Disclosure	2
Anxiety and Depressive Symptoms and Cortical Amyloid-β Burden in Cognitively Unimpaired Older Adults	2
Metformin in the Prevention of Alzheimer's Disease and Alzheimer's Disease Related Dementias	2
The Cost-Effectiveness of Three Prevention Strategies in Alzheimer's Disease: Results from the Multidomain Alzheimer Preventive Trial (MAPT)	2
Protocol for the Brain Health Support Program Study of the Canadian Therapeutic Platform Trial for Multidomain Interventions to Prevent Dementia (CAN-THUMBS UP): A Prospective 12-Month Intervention St	2
The impact of pre-analytical factors on plasma biomarkers for Alzheimer's disease: The ASPREE Healthy Ageing Biobank	2
Outreach, Screening, and Randomization of APOE ε4 Carriers into an Alzheimer's Prevention Trial: A global Perspective from the API Generation Program	2
Identifying proteomic prognostic markers for Alzheimer's disease with survival machine learning: The Framingham Heart Study	2
Distinct trajectories of subjective cognitive decline before diagnosis of neurocognitive disorders: Longitudinal modelling over 18 years	2
Physical and mental demands of work associated with dementia risk in later life	2
Sex Moderates the Association between Frailty and Mild Behavioral Impairment	2
Translating the Biology of Aging into New Therapeutics for Alzheimer's Disease: Senolytics	2
Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer's Disease	2
Aducanumab: Appropriate Use Recommendations Update	2
Beyond Frailty in Alzheimer's Disease: Should We Move to the Concept of Intrinsic Capacity?	2
Dominantly Inherited Alzheimer Network Trials Unit (DIAN-TU): Trial Satisfaction and Attitudes towards Future Clinical Trials	2
Association between the use of information and communication technology and cognitive decline stratified by social isolation: The Otassha study	2
Site Readiness Framework to Improve Health System Preparedness for a Potential New Alzheimer's Disease Treatment Paradigm	2
Independent and Joint Associations of Socioeconomic Status and Lifestyle behaviors with Cognitive Impairment among Elderly Chinese Population	2
Clinical Meaningfulness in Alzheimer's Disease Clinical Trials. A Report from the EU-US CTAD Task Force	2
Computerized Cognitive Training in Mild Cognitive Impairment: Findings in African Americans and Caucasians	2
Aducanumab: Appropriate Use Recommendations	2
Amyloid and APOE Status of Screened Subjects in the Elenbecestat MissionAD Phase 3 Program	2
Correlates of Subjective Cognitive Decline in Black American Men	2
Editorial Board	2
Characterizing and validating 12-month reliable cognitive change in Early-Onset Alzheimer's Disease for use in clinical trials	2
Longitudinal Phospho-tau217 Predicts Amyloid Positron Emission Tomography in Asymptomatic Alzheimer's Disease	2
Patient eligibility for amyloid-targeting immunotherapies in Alzheimer's disease	2
Cognitive Digital Biomarkers from Automated Transcription of Spoken Language	2
Roles of TREM2 in the Pathological Mechanism and the Therapeutic Strategies of Alzheimer's Disease	2
Metabolic Syndrome Status Changes and Cognitive Functioning: Insights from the Lifelines Cohort Study	2
Can We Use Blood Biomarkers as Entry Criteria and for Monitoring Drug Treatment Effects in Clinical Trials? A Report from the EU/US CTAD Task Force	2
Nutrition-Based Approaches in Clinical Trials Targeting Cognitive Function: Highlights of the CTAD 2020	2
How Modifiable Are Modifiable Dementia Risk Factors? A Framework for Considering the Modifiability of Dementia Risk Factors	2
A Large Retrospective Cohort Study on the Risk of Alzheimer's Disease and Related Dementias in Association with Vascular Diseases and Cancer Therapy in Men with Prostate Cancer	2
Validation of the multi-day Boston remote assessment of neurocognitive health (BRANCH) among cognitively impaired & unimpaired older adults	2
Alzheimer's Disease and Aging Association: Identification and Validation of Related Genes	2
Neuroinflammation Biomarkers in the AT(N) Framework Across the Alzheimer's Disease Continuum	2
Understanding Online Registry Facilitators and Barriers Experienced by Black Brain Health Registry Participants: The Community Engaged Digital Alzheimer's Research (CEDAR) Study	2
Behaviour change techniques used in interventions targeting dementia risk factors amongst older adults in rural and remote areas: A systematic review and meta-analysis	2
Donanemab: Appropriate use recommendations	2
Effect of a single nonpharmacological intervention on cognitive functioning in older adults with mild-to-moderate Alzheimer's disease: A meta-analysis of randomized controlled trials	1
Systematic and Comparative Analysis of the Burden of Alzheimer's Disease and Other Dementias in Mexico. Results at the National and Subnational Levels, 1990–2019	1
Can Virtual Scientific Conferences Facilitate Two-Way Learning between Dementia Researchers and Participants?	1
Flavonoid-Rich Fruit Intake in Midlife and Late-Life and Associations with Risk of Dementia: The Framingham Heart Study	1
The AlzMatch Pilot Study - Feasibility of Remote Blood Collection of Plasma Biomarkers for Preclinical Alzheimer's Disease Trials	1
Left Frontoparietal Control Network Connectivity Moderates the Effect of Amyloid on Cognitive Decline in Preclinical Alzheimer's Disease: The A4 Study	1
Childhood Secondhand Smoke Exposure and Risk of Dementia, Alzheimer's Disease and Stroke in Adulthood: A Prospective Cohort Study	1
Disease-Modifying Antirheumatic Drugs and Dementia Prevention: A Systematic Review of Observational Evidence in Rheumatoid Arthritis	1
Using Digital Tools to Advance Alzheimer's Drug Trials During a Pandemic: The EU/US CTAD Task Force	1
Longitudinal Impacts of Precision Greenness on Alzheimer's Disease	1
Later-Life Cognitive Trajectories and Risk of Death: Results from a 6-Year Longitudinal Study of 7082 Chinese	1
Alzheimer's Disease Linkage to Real-World Evidence (AD-LINE) Study: Linking Claims Data to Phase 3 GRADUATE Study of Gantenerumab	1
Cost-Effectiveness of Dementia Prevention Interventions	1
Hearing loss, diet, and cognitive decline: interconnections for dementia prevention	1
Lower Incidence of Dementia Following Cancer Diagnoses: Evidence from a Large Cohort and Mendelian Randomization Study	1
Association between Neuropsychological Performance and CSF Profile in Subjective Cognitive Decline: Towards the Diagnosis of Preclinical AD	1
Hypothetical Interventions on Cardiovascular Health Metrics for Abnormal Cognitive Aging: An Application of the Parametric g-formula in the CLHLS Cohort Study with 12 Years Follow-Up	1
Multimodal Precision Prevention - A New Direction in Alzheimer's Disease	1
Machine learning to detect Alzheimer's disease with data on drugs and diagnoses	1